At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Feb 24, 2026 at 19:00 ET
Two executives at Vertex Pharmaceuticals executed open-market share sales totaling $433K, while the same insiders also surrendered shares for tax withholding purposes related to equity compensation. The open-market sales are modest in value relative to the company's $122.5B market cap.
- EVP Edward Atkinson sold 668 shares for $324,881.80 in an open-market transaction.
- SVP Kristen Ambrose sold 223 shares for $108,456.05 in an open-market transaction.
- Both executives also surrendered shares to cover tax liabilities from equity vesting: Atkinson (1,627 shares, $789,273.97) and Ambrose (546 shares, $264,870.06).
- Total open-market proceeds: $433,337.85; total tax-related share surrenders: ~$1.05M.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access